Consistently, IL-6/STAT3 signaling in cancerous EMT also results in the acquisition of cancer stemness in cancer cells; the self-renewal and population expansion of CSCs requires STAT3 in cooperation with stem-cell-associated transcription factors, such as NANOG [44]. The gene discussed is IL6; the disease is cancer.